van de Veerdonk Mariëlle C, Marcus J Tim, Westerhof Nico, de Man Frances S, Boonstra Anco, Heymans Martijn W, Bogaard Harm-Jan, Vonk Noordegraaf Anton
Department of Pulmonary Diseases, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
Department of Physics and Medical Technology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
Chest. 2015 Apr;147(4):1063-1071. doi: 10.1378/chest.14-0701.
Even after years of stable response to therapy, patients with idiopathic pulmonary arterial hypertension (IPAH) may show an unexpected clinical deterioration due to progressive right ventricular (RV) failure. Therefore, the aim of this study was to assess in 5-year clinically stable patients with IPAH whether initial differences or subsequent changes in RV volumes precede late clinical progression.
Included were 22 clinically stable patients with IPAH as reflected by stable or improving New York Heart Association functional class II-III and exercise capacity during 5 years of follow-up. Twelve patients subsequently remained stable during a total follow-up of 10 years, whereas 10 other patients showed late progression leading to death or lung transplantation after a follow-up of 8 years. All patients underwent right-sided heart catheterization and cardiac MRI at baseline and at 1½, 3½, 6½, and, if still alive, 10 years follow-up.
Baseline hemodynamics were comparable in both groups and remained unchanged during the entire follow-up period. Baseline RV end-systolic volume (RVESV) was higher and RV ejection fraction (RVEF) was lower in late-progressive patients. Late-progressive patients demonstrated a gradually increased RV end-diastolic volume and RVESV and a decline in RVEF, whereas long-term stable patients did not show any RV changes.
In patients with stable IPAH for 5 years, subsequent late disease progression is preceded by changes in RV volumes. The results indicate that monitoring RV volumes anticipates clinical worsening, even at a time of apparent clinical stability.
即使对治疗多年来反应稳定,特发性肺动脉高压(IPAH)患者仍可能因进行性右心室(RV)衰竭而出现意外的临床恶化。因此,本研究的目的是评估在5年临床稳定的IPAH患者中,RV容积的初始差异或随后的变化是否先于晚期临床进展。
纳入22例临床稳定的IPAH患者,其纽约心脏协会功能分级为II-III级且在5年随访期间运动能力稳定或改善。12例患者在10年的总随访期间保持稳定,而另外10例患者在8年随访后出现晚期进展,导致死亡或肺移植。所有患者在基线时以及随访1.5年、3.5年、6.5年时(若仍存活则在10年随访时)均接受了右心导管检查和心脏磁共振成像。
两组患者的基线血流动力学相当,且在整个随访期间保持不变。晚期进展患者的基线右心室收缩末期容积(RVESV)较高,右心室射血分数(RVEF)较低。晚期进展患者的右心室舒张末期容积和RVESV逐渐增加,RVEF下降,而长期稳定患者的RV没有任何变化。
在5年临床稳定的IPAH患者中,随后出现的晚期疾病进展之前存在RV容积的变化。结果表明,即使在临床明显稳定时,监测RV容积也能预测临床恶化。